The experience

NextGenRnD was founded to offer unparalleled R&D solutions to multidisciplinary problems encountered in chemistry, biotechnology, pharmaceutical industry, life sciences, food, agriculture, animal and human health.

We have been crafting and licensing innovative solutions to multidisciplinary R&D problems since 2016. Our solutions outcompeted hundreds of other solution proposals in the global open innovation marketplace. As a result, the licenses of various types (non-exclusive and exclusive) to use our custom-built R&D solutions were obtained by the leading pharmaceutical and biotech companies, universities and research institutes.

The following table summarizes some of our top achievements on Wazoku/InnoCentive.

Challenge		Company
Selective Conjugation Method for Small Format Antibodies		Debiopharm
New Formulations for Approved mRNA Vaccines		Debiopharm
Novel Models of Airway Smooth Muscle (ASM) Remodeling in Severe Asthma		Boehringer Ingelheim
New Solutions for Targeted Gene Therapy		Boehringer Ingelheim
Coccidiosis Prevention and Control in Poultry		Elanco
Prevention and Control of Enteropathy/Ileitis in Swine		Elanco
A Robust and Reproducible Assay for Monitoring Tau Aggregation		Servier
Delivery of Biomolecules to the Gastrointestinal Tract		AstraZeneca
PET Imaging Probes for Visualization and Quantification of Oligonucleotide Exposure		Anonymous
Strategies for Creating Attenuated Vaccines		Anonymous

We are behind the success stories of open innovation in Health Care and Life Sciences sector with the latest winning R&D solutions for Covid-19 vaccines and for antibody drug conjugate technology crafted by the founder of NextGenRnD.

NextGenRnD offers advisory services to help our clients solve their challenges. Be it research and development project or grant proposal, technology reverse or forward engineering. We are passionate about making technology and biotechnology projects happen.

It is by logic that we prove, but by intuition that we discover